Abstract
Objectives
This study’s aims were to describe the outcomes of patients with diabetes presenting with their first ED visit for hyperglycemia, and to identify predictors of recurrent ED visits for hyperglycemia.
Methods
Using linked databases, we conducted a population-based cohort study of adult and pediatric patients with types 1 and 2 diabetes presenting with a first ED visit for hyperglycemia from April 2010 to March 2020 in Ontario, Canada. We determined the proportion of patients with a recurrent ED visit for hyperglycemia within 30 days of the index visit. Using multivariable regression analysis, we examined clinical and socioeconomic predictors for recurrent visits.
Results
There were 779,632 patients with a first ED visit for hyperglycemia. Mean (SD) age was 64.3 (15.2) years; 47.7% were female. 11.0% had a recurrent visit for hyperglycemia within 30 days. Statistically significant predictors of a recurrent visit included: male sex, type 1 diabetes, regions with fewer visible minority groups and with less education or employment, higher hemoglobin A1C, more family physician or internist visits within the past year, being rostered to a family physician, previous ED visits in the past year, ED or hospitalization within the previous 14 days, access to homecare services, and previous hyperglycemia encounters in the past 5 years. Alcoholism and depression or anxiety were positive predictors for the 18–65 age group.
Conclusions
This population-level study identifies predictors of recurrent ED visits for hyperglycemia, including male sex, type 1 diabetes, regions with fewer visible minority groups and with less education or employment, higher hemoglobin A1C, higher previous healthcare system utilization (ED visits and hospitalization) for hyperglycemia, being rostered to a family physician, and access to homecare services. Knowledge of these predictors may be used to develop targeted interventions to improve patient outcomes and reduce healthcare system costs.
Abstrait
Objectifs
Les objectifs de cette étude étaient de décrire les résultats des patients diabétiques présentant leur première visite aux urgences pour hyperglycémie, et d’identifier les prédicteurs des visites récurrentes aux urgences pour hyperglycémie.
Méthodes
À l’aide de bases de données couplées, nous avons mené une étude de cohorte basée sur la population de patients adultes et pédiatriques atteints de diabète de type 1 et 2 présentant une première visite aux urgences pour l’hyperglycémie d’avril 2010 à mars 2020 en Ontario, au Canada. Nous avons déterminé la proportion de patients présentant une visite récurrente à l’urgence pour hyperglycémie dans les 30 jours suivant la visite d’index. À l’aide d’une analyse de régression multivariée, nous avons examiné les prédicteurs cliniques et socioéconomiques des visites récurrentes.
Résultats
Il y avait 779 632 patients avec une première visite à l’urgence pour hyperglycémie. L’âge moyen (ET) était de 64,3 (15,2) ans; 47,7% étaient des femmes. 11,0 % avaient une visite récurrente pour hyperglycémie dans les 30 jours. Les prédicteurs statistiquement significatifs d’une visite récurrente comprenaient le sexe masculin, le diabète de type 1, les régions comptant moins de groupes de minorités visibles et ayant moins d’études ou d’emploi, une hémoglobine A1C plus élevée, plus de visites chez un médecin de famille ou un interniste au cours de la dernière année, être inscrit auprès d’un médecin de famille, consulter le service d’urgence au cours de la dernière année, être hospitalisé au cours des 14 derniers jours, avoir accès à des services de soins à domicile et avoir été confronté à une hyperglycémie au cours des 5 dernières années. L’alcoolisme et la dépression ou l’anxiété étaient des prédicteurs positifs pour le groupe des 18-65 ans.
Conclusions
Cette étude au niveau de la population identifie des prédicteurs de visites récurrentes aux urgences pour l’hyperglycémie, y compris le sexe masculin, le diabète de type 1, les régions avec moins de groupes de minorités visibles et avec moins d’études ou d’emploi, plus d’hémoglobine A1C, l’utilisation antérieure plus élevée du système de soins de santé (visites aux urgences et hospitalisation) pour l’hyperglycémie, le fait d’être inscrit auprès d’un médecin de famille et l’accès aux services de soins à domicile. La connaissance de ces prédicteurs peut être utilisée pour élaborer des interventions ciblées afin d’améliorer les résultats pour les patients et de réduire les coûts du système de santé.
Similar content being viewed by others
Data availability
The data supporting the findings of this study are available from the corresponding author, upon reasonable request.
References
The Ambulatory and Hospital Care Statistics Branch, U.S. Bureau of the Census. National Hospital Ambulatory Medical Care Survey: 2019 emergency department summary tables.
https://www.cdc.gov/nchs/data/nhamcs/web_tables/2019-nhamcs-ed-web-tables-508.pdf. Accessed 27 Jul 2022
Yan JW, Gushulak KM, Columbus MP, et al. Sentinel visits in emergency department patients with diabetes mellitus as a warning sign for hyperglycemic emergencies. CJEM. 2017;20(2):230–7.
Yan JW, Gushulak KM, Columbus MP, et al. Risk factors for recurrent emergency department visits for hyperglycemia in patients with diabetes mellitus. Int J Emerg Med. 2017;10(1):23.
Benchimol EI, Smeeth L, Guttmann A, et al. The REporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med. 2015;12: e1001885.
Hux JE, Ivis F, Flintoft V, Bica A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002;25:512–6.
Matheson FI, Dunn JR, Smith KLW, et al. Development of the Canadian Marginalization index: a new tool for the study of inequality. Can J Public Health. 2012;103(8 Suppl 2):S12–6.
Levy AR, O’Brien BJ, Sellors C, et al. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol. 2003;10:67–71.
Iskander C, McArthur E, Nash DM, et al. Identifying Ontario geographic regions to assess adults who present to hospital with laboratory-defined conditions: a descriptive study. CMAJ Open. 2019;7(4):E624–9. https://doi.org/10.9778/cmajo.20190065.
Yan JW, Hamelin AL, Gushulak KM, et al. Hyperglycemia in young adults with types 1 and 2 diabetes seen in the emergency department: a health records review. Can J Diabetes. 2018;42(3):296–301.
Siddiqi L, Van Aarsen K, Iansavitchene A, Yan JW. Risk factors for adverse outcomes in hyperglycemic patients presenting to the emergency department: a systematic review. Can J Diabetes. 2019;43(5):361–9.
Yan JW, Liu S, Van Aarsen K, et al. Do adult patients with type 1 or 2 diabetes who present to the emergency department with hyperglycemia have improved outcomes if they have access to specialized diabetes care? Can J Diabetes. 2021;45(1):59–63.
Benoit SR, Hora I, Pasquel FJ, et al. Trends in emergency department visits and inpatient admissions for hyperglycemic crises in adults with diabetes in the US, 2006–2015. Diabetes Care. 2020;43(5):1057–64.
Zhong VW, Juhaeri J, Mayer-Davis EJ. Trends in hospital admission for diabetic ketoacidosis in adults with type 1 and type 2 diabetes in England, 1998–2013: a retrospective cohort study. Diabetes Care. 2018;41:1870–7.
Grucza RA, Sher KJ, Kerr WC, et al. Trends in adult alcohol use and binge drinking in the early 21st-century United States: a meta-analysis of 6 national survey series. Alcohol Clin Exp Res. 2018;42:1939–50.
Ontario marginalization index: frequently asked questions. https://www.publichealthontario.ca/-/media/documents/F/2018/faqs-on-marg.pdf. Accessed 22 Feb 2022
Yan JW, Azzam D, Columbus MP, et al. The experience of emergency department patients after a visit for hyperglycemia: implications for communication and factors affecting adherence post-discharge. EMJ. 2022;39:132–8.
Acknowledgements
We thank IQVIA Solutions Canada Inc. for use of their Drug Information File, the Ontario Ministry of Health for use of the Ontario Laboratories Information System (OLIS), and the Toronto Community Health Profiles Partnership for providing access to the Ontario Marginalization Index.
Funding
This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health (MOH) and the Ministry of Long-Term Care (MLTC). This study also received support from an Innovation Fund from the Academic Medical Organization of Southwestern Ontario (AMOSO) (grant no. INN21-004). JWY is supported as a Clinician Researcher by the Division of Emergency Medicine and Department of Medicine at Western University. This document used data adapted from the Statistics Canada Postal CodeOM Conversion File, which is based on data licensed from Canada Post Corporation, and/or data adapted from the Ontario MOH Postal Code Conversion File, which contains data copied under license from ©Canada Post Corporation and Statistics Canada. Parts of this material are based on data and/or information compiled and provided by the Canadian Institute for Health Information (CIHI), Ontario Health (OH) and the Ontario MOH. The analyses, conclusions, opinions and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement is intended or should be inferred.
Author information
Authors and Affiliations
Contributions
JY conceived and obtained research funding. JY, BV, BL, KVA, and KC designed the study. BL acquired and analyzed the data, and all authors assisted with interpretation of the data. JY drafted the manuscript, and all authors contributed substantially to its revision.
Corresponding author
Ethics declarations
Conflict of interest
Outside of this study, KC has received a research award sponsored in part by Astra Zeneca. She has attended conferences sponsored by Merck. She has received honoraria for delivering certified medical education from Sutherland Global Services Canada ULC, the Canadian Medical and Surgical Knowledge Translation Group and the CPD Network. There are no other conflicts of interest to declare.
Additional information
Presentations: A preliminary, abstract only version of this work was accepted for poster presentation at the Diabetes Canada annual conference, Calgary, Alberta, Canada, November 2022 (https://www.canadianjournalofdiabetes.com/article/S1499-2671(22)00299-4/fulltext) and oral presentation at the Canadian Association of Emergency Physicians annual conference, Toronto, Ontario, Canada, May 2023.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yan, J.W., Vujcic, B., Le, B.N. et al. Predictors of 30-day recurrent emergency department visits for hyperglycemia in patients with types 1 and 2 diabetes: a population-based cohort study. Can J Emerg Med (2024). https://doi.org/10.1007/s43678-024-00686-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s43678-024-00686-4